Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HMSC- A simple breast cancer screening device -- Ignore unavailable to you. Want to Upgrade?

To: FCC who wrote (206)	5/19/1998 11:45:00 AM
From: Q.	Read Replies (1) \| Respond to of 246

CEO Donald Brounstein resigns ====================================================================== CRANFORD, N.J., May 19 (Reuters) - Medical equipment maker HumaScan Inc. Tuesday said its chief executive and chairman, Donald Brounstein, resigned. The company named one of its directors, Elizabeth Tallett, as chairman and acting chief executive to replace Brounstein, who was also president. Tallett, 49, currently is president and chief executive of two start-up companies, Dioscor Inc. and and Ellard Pharmaceuticals Inc. Previously she was president and chief executive of Transcell Technologies Inc. from 1992 to 1996.

To: FCC who wrote (206)	5/20/1998 7:54:00 PM
From: joe	Read Replies (2) \| Respond to of 246

looks like they have made some changes for the better. clinical results that ended on april 30, 1998 will be published around the middle of june. if these results show the same effectivness as past results the stock should react positevly. this will certanly help with new sales, one of the main complaints of doctors was lack of current clinical trials. last week they just completed training all of the PSSI sales reps. PSSI recieves about a 40% margin on the sale of this product in comparison to about the 20% average of the rest of pssi's products. august is national breast cancer awareness month and if the clinicals prove solid in june this stock could start to make a seriuos move. according to the confrence call, they only need about 1000 doctors selling 4 units a day to break even. as of march 31, 1998 the had 330. with the results of good clinical trials this could be all of the ammunition that is needed to start a strong sales campaign. additionally, with the @ $6 million in cash/money market and no debt they certanly are not going out of business anytime soon. the short position is almost 10%, the shorts are obviously in the money at this time and it would only make sense to cover at least some of the position profitably. should be an interesting couple of weeks !!!!!